Category Archives: Food Safety News

FDA warns consumers about counterfeit version of Teva’s Adderall

The U.S. Food and Drug Administration is warning consumers and health care professionals about a counterfeit version of Teva Pharmaceutical Industries’ Adderall 30 milligram tablets that is being purchased on the Internet. Adderall, which is approved to treat attention deficit hyperactivity disorders (ADHD) and narcolepsy, is a prescription drug classified as a controlled substance – a class of drugs for which special controls are required for dispensing by pharmacists.

UPDATED: CORRECTED BEST BEFORE DATE Diamond Pet Foods Expands Voluntary Recall Diamond Naturals Small Breed Adult Dog Lamb & Rice Formula Dry Dog Food Production Code DSL 0801 Due to Small Potential for Salmonella Contamination

Diamond Pet Foods is expanding a voluntary recall to include its Diamond Naturals Small Breed Adult Dog Lamb & Rice Formula dry dog food manufactured on Aug. 26, 2011 due to potential exposure to Salmonella. No illnesses have been reported.
Read The Complete Story!

Cargill Animal Nutrition Conducts Regional Recall of Select Animal Feed Products

December 14, 2011 – Cargill Animal Nutrition today announced a voluntary recall of select regional poultry, calf, and whole and cracked corn products due to aflatoxin levels that were detected above the acceptable limit. The affected animal feed products were manufactured at Cargill’s Lecompte, Louisiana, facility between Sept. 6, 2011, and Dec. 1, 2011.
Read The Complete Story!

Nestlé Purina Voluntarily Recalls Single Lot of Therapeutic Canned Cat Food Due to A Low Level of Thiamine (Vitamin B1)

Nestlé Purina PetCare (NPP) is voluntarily recalling one specific lot of its Purina Veterinary Diets® OM Overweight Management canned cat food, available through veterinarians in the U.S. and Canada. This precautionary measure is being taken in response to one consumer complaint received by FDA.
Read The Complete Story!

FDA issues alert on potential dangers of unproven treatment for multiple sclerosis

The U.S. Food and Drug Administration is alerting health care professionals and patients about injuries and death associated with the use of an experimental procedure sometimes called “liberation therapy” or the “liberation procedure” to treat chronic cerebrospinal venous insufficiency (CCSVI).

FDA proposal aims to help reduce unnecessary radiation exposure for children

Today, the U.S. Food and Drug Administration announced that it is seeking public comment on a proposal encouraging manufacturers to consider the safety of children in the design of new X-ray imaging devices. In the draft guidance, FDA is recommending that manufacturers design new X-ray imaging devices with protocols and instructions that address use on pediatric patients.